September 20th - 22nd, 2021 | In-person & Virtual
Applied BioMath Presence
Presentation: Applied BioMath Assess™: An Early Feasibility Analysis Tool for Biotherapeutics
Presenter: John Burke, PhD, Co-Founder, President and CEO
Presentation Time: Tuesday, September 21st, at 10:30 a.m.
Early R&D poses many questions and challenges when determining if a biotherapeutic enters the portfolio, and if so, what are its design characteristics? Some of the questions include an assessment of unmet medical need, competitive landscape, intellectual property, reimbursement, and difficulties of developability. Applied BioMath Assess is a new, interactive, web-based application that helps project leaders, protein engineers and chemists, and modelers assess the difficulties and risks in developing a therapeutic very early-on in a project.
Title: Leveraging ML/AI Tools for Robust Identification of Potential Biomarkers in Drug Response
Presented by: Sharvari Gujja, MS, Senior Principal Scientist, Applied BioMath